These data may suggest that CXCR3+ memory B cells—which drive hyperreactive B–T cell interactions in MS2 and show a high ASC differentiation capacity [8]—could redistribute to the CNS of individuals with longstanding progressive MS [3, 4]. Here, CXCR3 is linked to myeloid sarcoma.